Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 9:30 pm Purchase |
2024-12-31 | 13G | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 171,000 4.920% |
130,968 (+327.16%) |
Filing History |
| 2024-01-19 10:31 am Purchase |
2023-12-31 | 13G | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 40,032 9.990% |
2,871 (+7.73%) |
Filing History |
| 2023-09-08 06:07 am Unchanged |
2023-07-06 | 13G | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 37,161 9.900% |
0 (Unchanged) |
Filing History |
| 2023-08-24 08:20 am Purchase |
2022-05-19 | 13G | Comera Life Sciences Holdings, Inc. CMRA |
Nicholas Jason Singer | 1,445,448 5.170% |
1,445,448 (New Position) |
Filing History |
| 2023-07-26 5:05 pm Purchase |
2023-04-03 | 13D | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 37,161 9.990% |
37,161 (New Position) |
Filing History |
| 2022-12-20 4:30 pm Sale |
2022-12-02 | 13D | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 26,251 7.670% |
-113,416 (-81.20%) |
Filing History |
| 2022-02-16 5:15 pm Sale |
2021-12-31 | 13G | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 6,983 4.000% |
-5,657 (-44.75%) |
Filing History |
| 2021-04-30 4:05 pm Purchase |
2021-03-25 | 13G | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 12,640 9.130% |
12,640 (New Position) |
Filing History |